Krajina: Írsko
Jazyk: angličtina
Zdroj: HPRA (Health Products Regulatory Authority)
INACTIVATED SALMON PANCREAS DISEASE VIRUS, INACTIVATED INFECTIOUS PANCREATIC NECROSIS VIRUS, INACTIVATED AEROMONAS SALMONICIDA SUBSP. SALMONICIDA
Intervet Ireland Limited
QI10AL
INACTIVATED SALMON PANCREAS DISEASE VIRUS, INACTIVATED INFECTIOUS PANCREATIC NECROSIS VIRUS, INACTIVATED AEROMONAS SALMONICIDA S
75
Emulsion for Injection
POM
Fish - (Atlantic) Salmon
Inactivated viral and inactivated bacterial vaccines
Immunological - Inactivated vaccine
Authorised
2015-03-27
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT AquaVac PD3 Emulsion for injection, for Atlantic salmon 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Per dose of 0.1 ml vaccine: ACTIVE SUBSTANCE: Salmon pancreas disease virus (SPDV) strain F93-125, 75% RPP 1 Infectious pancreatic necrosis virus (IPNV), 1.5 ELISA units 2 _Aeromonas salmonicida _subsp. _salmonicida_, 80% RPS 60 3 1 RPP: relative percentage protection in a laboratory test in Atlantic salmon 2 Antigenic mass measured in the final product 3 RPS: relative percentage survival at 60% control mortality in a laboratory test in Atlantic salmon ADJUVANT: Light liquid paraffin, 43 mg For a full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM White to nearly white emulsion for injection. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Atlantic salmon (_Salmo salar _L). 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For active immunisation of Atlantic salmon to reduce clinical signs (heart lesions and pancreas lesions), viremia, viral shedding and mortality from infection with SPDV (Pancreas disease) and to reduce mortality from infections with IPNV (Infectious pancreatic necrosis) and _Aeromonas salmonicida _subsp. _salmonicida _(furunculosis). Onset of immunity: 500 degree days after vaccination for SPDV and _Aeromonas salmonicida _and 540 degree days after vaccination for IPNV. Duration of immunity: demonstrated at 15 months post vaccination for SPDV and at 16 months post vaccination for _Aeromonas salmonicida_. Protection against mortality due to IPNV infection has been demonstrated at 4 months post vaccination in the field. 4.3 CONTRAINDICATIONS None. HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printe Prečítajte si celý dokument